| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Biotricity (OTC:BTCY) reported quarterly losses of $(0.03) per share. This is a 61.33 percent increase over losses of $(0.07) p...
HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Neutral.
Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consu...
Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consu...
Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare indu...
Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) ...